Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.34 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.34 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.34 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13619939 | 0.77 | ALDH1A1 (0.44) | ALDH1A1HSD17B10GAASMN1; SMN2TSHR | |
| SCHEMBL13619908 | 0.76 | ALDH1A1 (0.40) | ALDH1A1HSD17B10ALOX15FBP1SMN1; SMN2 | |
| SCHEMBL16730126 | 0.75 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL13619907 | 0.73 | MAPT (0.50) | ALDH1A1HSD17B10GAACES1SMN1; SMN2 | |
| SCHEMBL10793008 | 0.69 | KIF11 (0.47) | KIF11HTR3EHTR3BPLAUHTR3A | |
| SCHEMBL2056226 | 0.69 | SLC2A1 (0.58) | KIF11ALDH1A1HSD17B10GAAALOX15 | |
| SCHEMBL13367596 | 0.69 | KIF11 (0.50) | KIF11ALDH1A1CES2CES1ORAI1 | |
| SCHEMBL14438096 | 0.67 | KIF11 (0.41) | KIF11HTR3EHTR3BPLAUHTR3A | |
| SCHEMBL18685866 | 0.66 | KIF11 (0.52) | KIF11HTR3EHTR3BPLAUHTR3A | |
| SCHEMBL11874585 | 0.66 | SMN1; SMN2 (0.42) | KIF11FBP1CES2CES1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10273202-B2 | Nitroxyl progenitor compounds and methods of use | THE JOHNS HOPKINS UNIVERSITY (US) | 2019-04-30 | — | — | US | disclosed |
| US-20150141378-A1 | NITROXYL PROGENITOR COMPOUNDS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-05-21 | — | — | US | disclosed |
| US-20090281067-A1 | Nitroxyl progenitor compounds and methods of use | THE JOHN HOPKINS UNIVERSITY (US) | 2009-11-12 | — | — | US | disclosed |
| US-20090281067-A1 | Nitroxyl progenitor compounds and methods of use | THE JOHN HOPKINS UNIVERSITY (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281067-A1 | Nitroxyl progenitor compounds and methods of use | HMOX2, NNMT, HMOX1 | KIF11 3304/4885HTR3E 2080/4885HTR3B 2302/4885 |
| US-20150141378-A1 | NITROXYL PROGENITOR COMPOUNDS AND METHODS OF USE | HMOX2, NNMT, HMOX1 | KIF11 3304/4885HTR3E 2080/4885HTR3B 2302/4885 |
| US-10273202-B2 | Nitroxyl progenitor compounds and methods of use | HMOX2, NNMT, HMOX1 | KIF11 3304/4885HTR3E 2080/4885HTR3B 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.